Armenia COVID-19 Employer Resources

The Armenian government has commissioned 600,000 doses of coronavirus vaccines from World Health Organization-backed COVAX Facility and hopes to receive their first batch in February. They will be enough to vaccinate 300,000 people making up roughly 10 percent of Armenia’s population. According to Gayane Sahakyan, the deputy director of the National Center for Disease Control and Prevention, medical and social workers, seniors and people suffering from chronic diseases will be the first to get vaccine shots free of charge. “It is expected that the manufacturer will deliver it to COVAX in February or March.” 


COVID-19 vaccine considerations for Armenia

  • Can employers mandate the vaccine?
  • Who will control delivery of the vaccine?
    Ministry of Health
  • Who covers the cost of the vaccine?
  • Where will people get vaccinated?
    Government designated vaccination locations
  • Is there cultural resistance to getting the vaccine?

Ministry of Health of Armenia has provisionally ordered a vaccine for 10% of population (about 300,000 persons) which will probably be delivered in spring.
The quantity is not limited and can be increased upon the demand.
The main group of taking the vaccine will be elderly people with chronic diseases, persons living in closed areas as well as medical personnel.

More Information

Ministry of Health of Armenia

Find the latest news about the Covid -19 Vaccine in Armenia here.

This information is provided by GrECo Group, Asinta's partner in Armenia.

Employee Benefits in Armenia

Get insights on mandatory and common supplementary employee benefits in Armenia.

Learn More

Top 6 Vaccine Considerations

Use our decision matrix to help support your employees.

Learn More

Page last modified: March 8, 2021

The information presented on this site is current as of the date initially posted; and, because matters related to COVID-19, the vaccine, and compliance measures are changing so quickly, it may not be current as of the date you read it. While the information gathered here is from Asinta global partners who are subject matter experts in their respective fields, this information is not meant to be a substitute for individual legal or medical advice, or as a substitute for advice in your specific situation.